Reckitt Benckiser Group (LON:RB)‘s stock had its “overweight” rating restated by research analysts at J P Morgan Chase & Co in a research note issued to investors on Tuesday, December 5th. They currently have a GBX 7,500 ($100.94) price target on the stock. J P Morgan Chase & Co’s price objective indicates a potential upside of 11.16% from the stock’s current price.
Several other research firms have also issued reports on RB. Liberum Capital reaffirmed a “buy” rating and issued a GBX 8,700 ($117.09) price objective on shares of Reckitt Benckiser Group in a research note on Wednesday, August 30th. BNP Paribas set a GBX 7,700 ($103.63) price objective on Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Tuesday, September 5th. Societe Generale set a GBX 7,800 ($104.98) price objective on Reckitt Benckiser Group and gave the company a “neutral” rating in a research note on Tuesday, September 5th. Whitman Howard reaffirmed a “buy” rating and issued a GBX 9,000 ($121.13) price objective on shares of Reckitt Benckiser Group in a research note on Monday, October 16th. Finally, Credit Suisse Group reaffirmed an “outperform” rating and issued a GBX 7,700 ($103.63) price objective on shares of Reckitt Benckiser Group in a research note on Friday, October 13th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and nine have given a buy rating to the company. Reckitt Benckiser Group has a consensus rating of “Hold” and a consensus target price of GBX 7,723.64 ($103.95).
Shares of Reckitt Benckiser Group (LON RB) opened at GBX 6,747 ($90.81) on Tuesday. Reckitt Benckiser Group has a one year low of GBX 6,299 ($84.78) and a one year high of GBX 8,110.43 ($109.16).
In other news, insider Adrian Nevil Hennah acquired 2,285 shares of Reckitt Benckiser Group stock in a transaction on Wednesday, November 8th. The shares were bought at an average cost of GBX 6,567 ($88.38) per share, for a total transaction of £150,055.95 ($201,959.56). Also, insider Christopher Sinclair acquired 2,800 shares of Reckitt Benckiser Group stock in a transaction on Wednesday, November 1st. The shares were purchased at an average price of GBX 6,597 ($88.79) per share, for a total transaction of £184,716 ($248,608.34).
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://www.dispatchtribunal.com/2017/12/14/reckitt-benckiser-group-rb-earns-overweight-rating-from-j-p-morgan-chase-co.html.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.